A Study to Assess the Effect of Rifampin on the Metabolism of ABT-199
Status:
Withdrawn
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
This is an open-label multicenter, study to assess the pharmacokinetic interaction of
rifampin with ABT-199 in up to 12 subjects with relapsed or refractory non-Hodgkin's
lymphoma.